Standard News

Hide Advertisement
  • Business
  • Culture
  • News
  • Technology
  • Trending
Site logo
ADVERTISEMENT
ADVERTISEMENT

Mylan hit with class action lawsuit over EpiPen pricing

By Reuters 2 min read
Advertisement - Continue reading below
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington

By Brendan Pierson

(Reuters) – An Ohio woman on Tuesday filed a proposed class action lawsuit against Mylan Pharmaceuticals Inc <MYL.O> in an Ohio county court, claiming sharp price hikes for the company’s EpiPen device violated the state’s consumer protection law.

Advertisement

Mylan has raised the U.S. price of EpiPen, which is used to treat life-threatening allergies, from less than $100 when it acquired the product in 2007 to more than $600, drawing criticism from parents, consumer groups and U.S. politicians.

EpiPens automatically inject a dose of the drug epinephrine into the thigh to counter dangerous reactions to allergens such as peanuts, foods and bee stings. It has a 94 percent share of the market for such auto-injector devices.

A Mylan spokeswoman, Nina Devlin, had no immediate comment.

The company has defended EpiPen’s high price, saying it spent hundreds of millions of dollars to improve the product. It has also said it recoups less than half the list price for EpiPens.

Tuesday’s lawsuit was filed in the Court of Common Pleas for Hamilton County, Ohio, by Cincinnati resident Linda Bates, whose son requires an EpiPen.

“The outrageous, unconscionable and immoral high prices set by Defendant is nothing more than price gouging,” the complaint says.

It says the price increases violated the Ohio Consumer Sales Practices Act, which prohibits “unconscionable” acts in connection with consumer transactions, including taking advantage of a consumer’s “physical infirmities.”

Bates is seeking to represent a class of individuals in Ohio who purchased EpiPens from 2007 the present, which will require her to show that a class action is the most fair way to resolve the case.

In response to pressure from U.S. lawmakers, Mylan said last month that it would expand discount programs and launch a generic version of EpiPen for $300.

Nonetheless, U.S. Senators Richard Blumenthal and Amy Klobuchar, both Democrats, on Tuesday called on the U.S. Federal Trade Commission to issue a subpoena to Mylan about EpiPen’s pricing.

The same day, New York Attorney General Eric Schneiderman announced he was launching his own investigation of whether Mylan violated antitrust laws in its contracts to provide EpiPens to some school systems.

The company is also facing a separate proposed class action lawsuit accusing it of gouging consumers by selling EpiPens only in packs of two. It was filed in late August in federal court in Michigan.

(Reporting by Brendan Pierson in New York; Editing by Alexia Garamfalvi and Dan Grebler)

tagreuters.com2016binary_LYNXNPEC8518B-VIEWIMAGE

Advertisement - Continue reading below

Sanders rejects deal on Puerto Rico, offers alternative
News
Reuters 2 min read

Sanders rejects deal on Puerto Rico, offers alternative

U.S. House Democrats’ Pelosi: administration may shift funds for Zika
News
Reuters 2 min read

U.S. House Democrats’ Pelosi: administration may shift funds for Zika

‘Orange is the New Black’ season 4 deals with racism, privatization
Entertainment
Reuters 2 min read

‘Orange is the New Black’ season 4 deals with racism, privatization

Immigration, abortion, race rulings due at Supreme Court
News
Reuters 2 min read

Immigration, abortion, race rulings due at Supreme Court

Up to $3.5 billion of airport bonds clear Chicago council committee
News
Reuters 1 min read

Up to $3.5 billion of airport bonds clear Chicago council committee

California governor signs epinephrine bill, blasts Mylan
News
Reuters 2 min read

California governor signs epinephrine bill, blasts Mylan

Bill allowing guns on Tennessee campuses becomes law
News
Reuters 2 min read

Bill allowing guns on Tennessee campuses becomes law

Beyond the Crowds: Exploring Alternatives to the Most Overvisited Travel Destinations in 2023
Culture
tgreen 2 min read

Beyond the Crowds: Exploring Alternatives to the Most Overvisited Travel Destinations in 2023

Larson back at Toronto Film Festival with shoot-em-up caper ‘Free Fire’
Entertainment
Reuters 2 min read

Larson back at Toronto Film Festival with shoot-em-up caper ‘Free Fire’

Lockheed wins $424 million contract for radar emitter simulation products: Pentagon
News
Reuters 1 min read

Lockheed wins $424 million contract for radar emitter simulation products: Pentagon

load more Loading posts...

sidebar

ADVERTISEMENT
ADVERTISEMENT

sidebar-alt

  • About Us
  • Imprint
  • Contact Us
  • Terms of Service
  • Privacy Policy
  • For Advertisers